DK1161562T3 - Deleterede sekvenser i M. bovis BCG/M. bovis eller M. tuberculosis, fremgangsmåde til påvisning af mykobakterier ved anvendelse af sekvenserne og vacciner - Google Patents

Deleterede sekvenser i M. bovis BCG/M. bovis eller M. tuberculosis, fremgangsmåde til påvisning af mykobakterier ved anvendelse af sekvenserne og vacciner

Info

Publication number
DK1161562T3
DK1161562T3 DK00910960T DK00910960T DK1161562T3 DK 1161562 T3 DK1161562 T3 DK 1161562T3 DK 00910960 T DK00910960 T DK 00910960T DK 00910960 T DK00910960 T DK 00910960T DK 1161562 T3 DK1161562 T3 DK 1161562T3
Authority
DK
Denmark
Prior art keywords
sequences
bovis
tuberculosis
vaccines
bcg
Prior art date
Application number
DK00910960T
Other languages
English (en)
Inventor
Stewart Cole
Stephen Gordon
Roland Buchrieser-Brosch
Alain Billault
Thierry Garnier
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of DK1161562T3 publication Critical patent/DK1161562T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK00910960T 1999-03-16 2000-03-16 Deleterede sekvenser i M. bovis BCG/M. bovis eller M. tuberculosis, fremgangsmåde til påvisning af mykobakterier ved anvendelse af sekvenserne og vacciner DK1161562T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9903250A FR2791067B1 (fr) 1999-03-16 1999-03-16 Sequence deletees chez m.bovis bcg/m.ou m.tuberculosis, procede de detection des mycobacteries utilisant ces sequences et vaccins
PCT/FR2000/000637 WO2000055362A1 (fr) 1999-03-16 2000-03-16 Sequences deletees chez m. bovis bcg/m. bovis ou m. tuberculosis, procede de detection des mycobacteries utilisant ces sequences et vaccins

Publications (1)

Publication Number Publication Date
DK1161562T3 true DK1161562T3 (da) 2009-06-29

Family

ID=9543261

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00910960T DK1161562T3 (da) 1999-03-16 2000-03-16 Deleterede sekvenser i M. bovis BCG/M. bovis eller M. tuberculosis, fremgangsmåde til påvisning af mykobakterier ved anvendelse af sekvenserne og vacciner

Country Status (12)

Country Link
US (2) US8357493B2 (da)
EP (1) EP1161562B9 (da)
AT (1) ATE432360T1 (da)
AU (1) AU3298900A (da)
CA (1) CA2368088C (da)
CY (1) CY1109210T1 (da)
DE (1) DE60042268D1 (da)
DK (1) DK1161562T3 (da)
ES (1) ES2326358T3 (da)
FR (1) FR2791067B1 (da)
PT (1) PT1161562E (da)
WO (1) WO2000055362A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2286212T3 (es) * 2002-02-25 2007-12-01 Pasteur Institut Secuencias suprimidas especificamente del genoma de mycobacterium tuberculosis, y su uso en el diagnostico y como vacunas.
US20050058663A1 (en) * 2003-09-17 2005-03-17 Monif Gilles R. G. Mycobacterium avium subspecies paratuberculosis oral vaccine and methods
US20080206776A1 (en) 2005-09-05 2008-08-28 Bio-Rad Pasteur Use of Both Rd9 and Is6110 as Nucleic Acid Targets for the Diagnosis of Tuberculosis, and Provision of Multiplex-Compliant Is6110 and Rd9 Targets
US8961989B2 (en) 2009-11-20 2015-02-24 Oregon Health & Science University Methods for producing an immune response to tuberculosis
US9128098B2 (en) 2012-10-31 2015-09-08 Gilles R. G. Monif Fuidi herd management and risk stratification methods
GB201314873D0 (en) * 2013-08-20 2013-10-02 Univ Cape Town Method for diagnosing tuberculosis in a urine sample
CN108949783B (zh) * 2017-05-19 2021-03-26 复旦大学 一种重组卡介苗及其应用
EP3735476B1 (en) 2018-01-05 2023-08-23 Seegene, Inc. Method for determining the presence or absence of m. tuberculosis, m. bovis and m. bovis bcg in a sample
CN110129465B (zh) * 2019-05-22 2023-08-22 杭州优思达生物技术股份有限公司 一种海分枝杆菌核酸的快速检测方法及其试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656493A (en) * 1985-03-28 1997-08-12 The Perkin-Elmer Corporation System for automated performance of the polymerase chain reaction
FR2663033B1 (fr) * 1990-06-08 1992-09-04 Pasteur Institut Detection specifique du mycobacterium tuberculosis.
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
WO1997029212A1 (en) 1996-02-08 1997-08-14 Affymetrix, Inc. Chip-based speciation and phenotypic characterization of microorganisms
US6183957B1 (en) 1998-04-16 2001-02-06 Institut Pasteur Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library application to the detection of mycobacteria
US6294328B1 (en) * 1998-06-24 2001-09-25 The Institute For Genomic Research DNA sequences for strain analysis in Mycobacterium tuberculosis
US6291190B1 (en) * 1998-08-25 2001-09-18 The Board Of Trustees Of The Leland Stanford Junior University Molecular differences between species of the M. tuberculosis complex

Also Published As

Publication number Publication date
US20050250120A1 (en) 2005-11-10
ATE432360T1 (de) 2009-06-15
AU3298900A (en) 2000-10-04
PT1161562E (pt) 2009-07-03
WO2000055362A1 (fr) 2000-09-21
ES2326358T3 (es) 2009-10-08
CA2368088C (fr) 2012-08-07
FR2791067B1 (fr) 2003-01-31
CA2368088A1 (fr) 2000-09-21
US20130164749A1 (en) 2013-06-27
EP1161562B1 (fr) 2009-05-27
EP1161562B9 (fr) 2011-09-28
FR2791067A1 (fr) 2000-09-22
DE60042268D1 (de) 2009-07-09
US8357493B2 (en) 2013-01-22
CY1109210T1 (el) 2014-07-02
EP1161562A1 (fr) 2001-12-12

Similar Documents

Publication Publication Date Title
CY1109210T1 (el) Διαγραφεισες αλληλουχιες στο μ. bovis bcg/m. bovis ΄η μ. tuberculosis, μεθοδος ανιχνευσεως μυκοβακτηριων που χρησιμοποιουν αυτες τις αλληλουχιες και εμβολια
DK1051506T3 (da) Fremgangsmåde til ekstraktion og isolation af bakterielle kapsel-polysaccharider til anvendelse som vaccine eller sammenkoblet med proteiner som konjugerede vacciner
CY1109652T1 (el) Lawsonia intracellularis ευρωπαϊκης προελευσεως και εμβολια, διαγνωστικοι παραγοντες και μεθοδοι χρησεως τους
AR054477A1 (es) Vacunas para inmunizacion contra helicobacter
DK1347055T3 (da) Forbindelser til immunbehandling og diagnose af tuberkulose
DK0527760T3 (da) Fremgangsmåder og præparater til vaccination mod HIV
WO2006017856A3 (en) Methods for constructing antibiotic resistance free vaccines
FI854143A0 (fi) Itsenäisiä replikointisekvenssejä Pichia-hiivakannoille
AU2003244855A1 (en) Method to enhance an immune response of nucleic acid vaccination
CY1106584T1 (el) Αλληλουχιες που εξαλειφονται ειδικα απο το γονιδιωμα του μυκοβακτηριου της φυματιωσης (mycobacterium tuberculosis ) και η χρηση τους στη διαγνωστικη και σαν εμβολια
WO2002033116A3 (en) Nucleic acid ligands to the prostate specific membrane antigen
CY1108255T1 (el) Μεθοδος για τη συνθεση μιας ενωσης βενζιμιδαζολης
AU2883897A (en) Spruce budworm antifreeze proteins, genes and methods of using same
DK1154791T3 (da) Neisseria-vaccinesammensætninger og fremgangsmåder
WO2004083448A3 (en) Molecular differences between species of the m.tuberculosis complex
ATE442858T1 (de) Nukleinsäureadjuvantien
WO2002044406A3 (en) Projection against mycobacterial infections
WO2004102199A3 (en) Method for selecting and producing vaccine components and vaccines based thereon
WO2003093416A3 (en) Protective antigens for the control of ixodes species infestations
FI971402A (fi) Menetelmä voimistettujen antigeenisten Helico-bacter-lajien ja niitä sisältävien rokotteiden valmistamiseksi
DK1227840T3 (da) Adjuverede, genetiske vacciner
Blaser et al. Antisera against a Peb1 antigen from campylobacter jejuni
BRPI0303416B8 (pt) processos de obtenção do lipopolissacarídeo de bordetella pertussis e de obtenção e preparação do lipídeo-a monofosforilado de bordetella pertussis, uso do lipídeo-a monofosforilado de bordetella pertussis e vacinas
DE60031106D1 (de) Fluordesoxyuridin-resistente streptococcus gordonii stämme
BR0303762A (pt) Processos de obtenção do lipopolissacarìdeo de bordetella pertussis e de obtenção e preparação do lipìdeo a monofosforilado de bordetella pertussis, e de uso do lipìdeo a monofosforilado de bordetella pertussus como adjuvante em imunizações e vacinas